| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.07 |